1,671
Views
12
CrossRef citations to date
0
Altmetric
Review

Systematic literature review comparing rapid 3-dose administration of the GSK tick-borne encephalitis vaccine with other primary immunization schedules

, , , , &
Pages 919-932 | Received 05 Apr 2017, Accepted 19 Jul 2017, Published online: 04 Aug 2017

References

  • Fischer M, Rabe IB, Rollin PE. Tickborne encephalitis. In: Brunette GW, editor. Chief, centers for disease control and prevention. Oxford, UK: Oxford University Press;2016. Yellow Book. [cited 2016 Oct 25]. Available from: http://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/tickborne-encephalitis
  • Han MH, Zunt JR. Neurologic aspects of infections in international travelers. Neurologist. 2005;11:30–44.
  • ECDC. Epidemiological situation of tick-borne encephalitis in the European Union and European Free Trade Association countries. [cited 2017 Feb 24]. Available from: http://www.ecdc.europa.eu/en/publications/Publications/TBE-in-EU-EFTA.pdf
  • Amicizia D, Domnich A, Panatto D, et al. Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines. Human Vacc Immunother. 2013;9:1163–1171.
  • Grygorczuk S, Osada J, Parczewski M, et al. The expression of the chemokine receptor CCR5 in tick-borne encephalitis. J Neuroinflammation. 2016;13:45.
  • Lindquist L, Vapalahti O. Tick borne encephalitis. Lancet. 2008;371:1861–1871.
  • Heinz FX, Stiasny K, Holzmann H, et al. Vaccination and Tick-borne encephalitis, Central Europe. Emerg Infect Dis. 2013;19:69–76.
  • Süss J. Tick-borne encephalitis 2010: epidemiology, risk areas, and virus strains in Europe and Asia-an overview. Ticks Tick Borne Dis. 2011;2(1):2–15.
  • Donoso Mantke O, Escadafal C, Niedrig M, et al. Tick-borne encephalitis in Europe, 2007 to 2009. Euro Surveill. 2011;16:39.
  • Daniel M, Kříž B, Danielová V, et al. Sudden increase in tick-borne encephalitis cases in the Czech Republic, 2006. Int J Med Microbiol. 2008;298(SUPPL. 1):81–87.
  • Grgic-Vitek M, Klavs I. High burden of tick-borne encephalitis in Slovenia–challenge for vaccination policy. Vaccine. 2011;29:5178–5183.
  • Karelis G, Bormane A, Logina I, et al. Tick-borne encephalitis in Latvia 1973–2009: epidemiology, clinical features and sequelae. Eur J Neurol. 2012;19:62–68.
  • Kriz B, Maly M, Benes C, et al. Epidemiology of tick-borne encephalitis in the Czech Republic 1970–2008. Vector Borne Zoonotic Dis. 2012;12:994–999.
  • Zenz W, Pansi H, Zoehrer B, et al. Tick-borne encephalitis in children in Styria and Slovenia between 1980 and 2003. Pediatr Inf Dis J. 2005;24:892–896.
  • European Centre for disease Prevention and Control (ECDC). Epidemiological situation of tick-borne encephalitis in the European Union and European Free Trade Association countries. Stockholm: ECDC; 2012. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/TBE-in-EU-EFTA.pdf
  • Schuler M, Zimmermann H, Altpeter E, et al. Epidemiology of tick-borne encephalitis in Switzerland, 2005 to 2011. Eurosurveillance. 2014;19:13.
  • Altpeter E, Zimmermann H, Oberreich J, et al. Tick related diseases in Switzerland, 2008 to 2011. Swiss Med Wkly. 2013;143:w13725.
  • Dorko E, Rimarova K, Kizek P, et al. Increasing incidence of tick-borne encephalitis and its importance in the Slovak Republic. Central Eur J Public Health. 2014;22:277–281.
  • Rezza G, Farchi F, Pezzotti P, et al. Tick-borne encephalitis in north-east Italy: a 14-year retrospective study, January 2000 to December 2013. Euro Surveill. 2015;20:40.
  • Zielinski A, Czarkowski MP, Sadkowska-Todys M. Infectious diseases in Poland in 2011. Przegl Epidemiol. 2013;67(171–9):301–305.
  • Zoldi V, Juhasz A, Nagy C, et al. Tick-borne encephalitis and Lyme disease in Hungary: the epidemiological situation between 1998 and 2008. Vector Borne Zoonotic Dis. 2013;13:256–265.
  • WHO Position Paper. 2011. Vaccines against tick-borne encephalitis (TBE). [cited 2017 Jan 13]. Available from: http://www.who.int/immunization/TBE_duration_protection.pdf
  • Zent O, Hennig R. Post-marketing surveillance of immediate allergic reactions: polygeline-based versus polygeline-free pediatric TBE vaccine. Vaccine. 2004;23:579–584.
  • Zent O, Hennig R, Banzhoff A, et al. Protection against tick-borne encephalitis with a new vaccine formulation free of protein-derived stabilizers. J Travel Med. 2005;12:85–93.
  • Higgins JPT, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: http://handbook.cochrane.org
  • Moher D, Liberati A, Tetzlaff J, et al. The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
  • Scottish Intercollegiate Guidelines Network. Critical appraisal: notes and checklists. [cited 2016 Oct 13]. Available from: http://www.sign.ac.uk/
  • Zent O, Beran J, Jilg W, et al. Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults. Vaccine. 2003;21:738–741.
  • Zent O, Jilg W, Plentz A, et al. Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule. Vaccine. 2003;21:4655–4660.
  • Zent O, Schwarz TF, Plentz A, et al. TBE booster immunization in adults–first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer. Int J Med Microbiol. 2004;293(Suppl 37):134–138.
  • Schöndorf I, Beran J, Cizkova D, et al. Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule. Vaccine. 2007;25:1470–1475.
  • Loew-Baselli A, Konior R, Pavlova BG, et al. Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies. Vaccine. 2006;24:5256–5263.
  • Jilkova E, Vejvalkova P, Stiborova I, et al. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly–results from an observational study. Exp Opin Biologic Ther. 2009;9:797–803.
  • Zent O, Plentz A, Schwarz TF, et al. TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary? Vaccine. 2004;23:312–315.
  • Plentz A, Jilg W, Schwarz TF, et al. Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults. Vaccine. 2009;27:853–856.
  • Beran J, Xie F, Zent O. Five year follow-up after a first booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates long-term antibody persistence and safety. Vaccine. 2014;32:4275–4280.
  • Schöndorf I, Schonfeld C, Nicolay U, et al. Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule. Int J Med Microbiol. 2006;296(Suppl 40):208–212.
  • Beran J, Douda P, Gniel D, et al. Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule. Int J Med Microbiol. 2004;293(Suppl 37):130–133.
  • Schoendorf I, Ternak G, Oroszlan G, et al. Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21). Hum Vaccine. 2007;3:42–47.
  • Zent O, Banzhoff A, Hilbert AK, et al. Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer. Vaccine. 2003;21:3584–3592.
  • Wittermann C, Petri E, Zent O. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children. Vaccine. 2009;27:1585–1588.
  • Wittermann C, Nicolay U, Hilbert AK, et al. Paediatric tick-borne encephalitis (TBE) vaccines: schedules to optimise protection. Int J Med Microbiol. 2008;298(SUPPL. 1):301–304.
  • Wittermann C, Izu A, Petri E, et al. Five year follow-up after primary vaccination against tick-borne encephalitis in children. Vaccine. 2015;33:1824–1829.
  • Wittermann C, Schöndorf I, Gniel D. Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules. Vaccine. 2009;27:1661–1666.
  • Pollabauer EM, Pavlova BG, Löw-Baselli A, et al. Comparison of immunogenicity and safety between two paediatric TBE vaccines. Vaccine. 2010;28:4680–4685.
  • Prymula R, Pollabauer EM, Pavlova BG, et al. Antibody persistence after two vaccinations with either FSME-IMMUN(R) Junior or ENCEPUR(R) Children followed by third vaccination with FSME-IMMUN(R) Junior. Human Vaccin Immunother. 2012;8:736–742.
  • Kollaritsch H, Paulke-Korinek M, Holzmann H, et al. Vaccines and vaccination against tick-borne encephalitis. Expert Rev Vaccines. 2012;11:1103–1119.
  • Pinti M, Appay V, Campisi J, et al. Aging of the immune system. Focus on inflammation and vaccination. Eur J Immunol. 2016;46:2286–2301.
  • Gnanasekaran G, Biedenbender R, Davidson HE, et al. Vaccinations for the older adult. Clin Geriatr Med. 2016;32:609–625.